Pharma companies consider ‘first sale’ rule to ease tariff impactnews2025-05-22T15:35:10+00:00May 22nd, 2025|Endpoints News|
Sanofi makes $470M move for Vigil’s Alzheimer’s drug, while another asset returns to Amgennews2025-05-22T08:15:14+00:00May 22nd, 2025|Endpoints News|
FDA adcomm votes unanimously against Pfizer’s prostate cancer drug combonews2025-05-22T00:12:45+00:00May 22nd, 2025|Endpoints News|
FDA asks Covid vaccine makers to add more myocarditis data to labelsnews2025-05-21T20:14:17+00:00May 21st, 2025|Endpoints News|
FDA announces efforts to facilitate drug importation from Canada news2025-05-21T20:02:27+00:00May 21st, 2025|Endpoints News|
Teva, Novartis get new FTC warnings over Orange Book listingsnews2025-05-21T19:38:06+00:00May 21st, 2025|Endpoints News|
FDA adcomm narrowly votes against UroGen’s bladder cancer drugnews2025-05-21T16:50:56+00:00May 21st, 2025|Endpoints News|
RFK Jr. spars with senators over HHS budget and research cutsnews2025-05-20T18:18:33+00:00May 20th, 2025|Endpoints News|
Trump administration reveals ‘most favored nation’ drug price country targetsnews2025-05-20T14:21:32+00:00May 20th, 2025|Endpoints News|
Pfizer joins PD-1xVEGF race with $1.25B upfront to Chinese biotech 3SBionews2025-05-20T07:24:02+00:00May 20th, 2025|Endpoints News|
